ation

Strength of
recommendation

Quality of
evidence

1.1

We recommend CTA as the initial diagnostic tool of choice for SAAs, with 1-mmthickness sections if available.

1 (Strong)

C (Low)

1.2

In patients with suspected SAAs and pre-existing renal insufÔ¨Åciency limiting the
use of iodinated contrast material, we recommend MRA to establish diagnosis.

1 (Strong)

C (Low)

1.3

We